Therefore, combined with our research results, in CTEPH atherosclerotic lesions, the IL-1β+ macrophage subtype derived from peripheral blood CD16+ monocytes play a major contributing role. The gene discussed is IL1B; the disease is chronic thromboembolic pulmonary hypertension.